Characterization of hepatitis B virus DNA polymerase.
Hepatitis B virus (HBV) particles were separated from the blood-plasma containing HBe and HBs antigens (subtype adr) and the nature of the endogenous DNA polymerase in the HBV core particles was studied. The HBV endogenous DNA polymerase activity was examined under the conditions used for preparation of HBV vaccine. The endogenous DNA polymerase activity was reduced slowly upon the heat treatment or the formalin treatment. The reductions of the activity were 65% and 70% upon the heat treatment at 60 C for 10 hr and the formalin treatment at 37 C for 90 hr, respectively. Properties of the HBV endogenous DNA polymerase were studied by utilizing specific inhibitors against the eukaryotic DNA polymerases. Our results showed that the HBV endogenous DNA polymerase is resistant to aphidicolin and N-ethylmaleimide, and sensitive to 2',3'-dideoxythymidine 5'-triphosphate, phosphonoformic acid and 9-beta-D-arabinofuranosyladenosine 5'-triphosphate.
D016590:Aphidicolin; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism*; D054306:Dideoxynucleotides; D004224:Diterpenes / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005557:Formaldehyde / Q000494:pharmacology; D017245:Foscarnet; D006515:Hepatitis B virus / Q000201:enzymology*; D006358:Hot Temperature; D019384:Nucleic Acid Synthesis Inhibitors; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D013942:Thymine Nucleotides / Q000494:pharmacology; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D014771:Virion / Q000201:enzymology*
D054306:Dideoxynucleotides; D004224:Diterpenes; D019384:Nucleic Acid Synthesis Inhibitors; D013942:Thymine Nucleotides; D001084:Vidarabine Phosphate; D005557:Formaldehyde; D017245:Foscarnet; C000101:ara-ATP; D016590:Aphidicolin; D004259:DNA-Directed DNA Polymerase; C017216:2',3'-dideoxythymidine triphosphate; D010746:Phosphonoacetic Acid; D005033:Ethylmaleimide